-
Journal of Pain Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Yellow flag scores in a compensable New Zealand cohort suffering acute low back pain
Original Research
(3374) Views (807) Full article downloads
Authors: Karen Grimmer-Somers, Mathew Prior, Jim Robertson
Published Date December 2008
Volume 2008:1 Pages 15 - 25
DOI: http://dx.doi.org/10.2147/JPR.S3710
Karen Grimmer-Somers1, Mathew Prior1, Jim Robertson2
1Centre for Allied Health Evidence, University of South Australia, City East Campus, North Tce, Adelaide, South Australia, Australia; 2New Zealand Accident Compensation Corporation, Auckland, New Zealand
Background: Despite its high prevalence, most acute low back pain (ALBP) is nonspecific, self-limiting with no definable pathology. Recurrence is prevalent, as is resultant chronicity. Psychosocial factors (yellow flags comprising depression and anxiety, negative pain beliefs, job dissatisfaction) are associated with the development of chronic LBP.
Methods: A national insurer (Accident Compensation Corporation, New Zealand [NZ]), in conjunction with a NZ primary health organization, piloted a strategy for more effective management of patients with ALBP, by following the NZ ALBP Guideline. The guidelines recommend the use of a psychosocial screening instrument (Yellow Flags Screening Instrument, a derivative of Örebro Musculoskeletal Pain Questionnaire). This instrument was recommended for administration on the second visit to a general medical practitioner (GP). This paper tests whether published cut-points of yellow flag scores to predict LBP claims length and costs were valid in this cohort.
Results: Data was available for 902 claimants appropriately enrolled into the pilot. 25% claimants consulted the GP once only, and thus were not requested to provide a yellow flag score. Yellow flag scores were provided by 48% claimants who consumed two or more GP services. Approximately 60% LBP presentations resolved within five GP visits. Yellow flag scores were significantly and positively associated with treatment costs and service use, although the association was nonlinear. Claimants with moderate yellow flag scores were similarly likely to incur lengthy claims as claimants with at-risk scores.
Discussion: Capturing data on psychosocial factors for compensable patients with ALBP has merit in predicting lengthy claims. The validity of the published yellow flag cut-points requires further testing.
Keywords: acute low back pain, yellow flags, clinical guideline, lengthy claims
Other articles by Professor Karen Grimmer-Somers
A review and critique of assessment instruments for patients with persistent painEffectiveness of a physiotherapy-initiated telephone triage of orthopedic waitlist patients
Extended scope physiotherapy roles for orthopedic outpatients: an update systematic review of the literature
Measuring children’s distress during burns dressing changes: literature search for measures appropriate for indigenous children in South Africa
Measuring the impact of allied health research
Pillow use: the behavior of cervical stiffness, headache and scapular/arm pain
Primary care assessment instruments for patients at risk of, or with, persistent pain: opportunistic findings from a systematic literature review
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- An eight-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia
- Problems and barriers of pain management in the emergency department: Are we ever going to get better?
- A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
- Anesthesiologists’ perception of patients’ anxiety under regional anesthesia




